Aspirin Enteric-Coated Tablets
Aspirin Enteric-Coated Tablets is a pharmaceutical drug with 7 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
6
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Weak Pulse at Yang and Wiry Pulse at Yin Theory
Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization
Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization
Clinical Trials (7)
Weak Pulse at Yang and Wiry Pulse at Yin Theory
Aspirin Treatment for Small Unruptured InTracranial Aneurysms With Ischemic cereBrovascuLar diseasE
Efficacy and Safety of Wen Xin Granules for the Treatment of Unstable Angina Pectoris
Curative Effect Evaluation of Danlou Tablet on Coronary Artery Disease Not Amenable to Revascularization
Curative Effect Evaluation of Shexiang Baoxin Pill on Coronary Artery Disease Not Amenable to Revascularization
Efficacy and Safety of Qizhitongluo Capsule in the Recovery Phase of Ischemic Stroke
A Clinical Trials of Quick-Acting Heart Reliever for Moderate Coronary Stenosis
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7